Takeda Pharmaceutical Co Ltd (NYSE:TAK) Q2 2021 Earnings Conference Call October 29, 2020 5:30 AM ET Company Participants Christopher O'Reilly - IR Christophe Weber - President, CEO & Representative Director Andrew Plump - President, Research & Development and Director Constantine Saroukos - CFO & Director Julie Kim - President, Plasma-Derived Therapies Business Unit Conference Call Participants Fumiyoshi Sakai - Crédit Suisse Hidemaru Yamaguchi - Citigroup Kazuaki Hashiguchi - Daiwa Securities Shinichiro M ...

COMMITTED TO BRINGING BETTER HEALTH AND A BRIGHTER FUTURE TO PEOPLE WORLDWIDE FY2020 Q2 Earnings Announcement October 29, 2020 Better Health, Brighter Future IMPORTANT NOTICE 1 For the purposes of this notice, "presentation" means this document, any oral presentation, any question and answer session and any written or oral material discussed or distributed by Takeda Pharmaceutical Company Limited ("Takeda") regarding this presentation. This presentation (including any oral briefing and any question-and-answ ...